Drug
Ixazomib
Ixazomib: highest development phase Phase 1, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ixazomib NCT02630030 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow Ixazomib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.